Tardif JC - Search Results

1

Resting heart rate: a modifiable prognostic indicator of cardiovascular risk and outcomes?

Arnold JM, Fitchett DH, Howlett JG, Lonn EM, Tardif JC. Arnold JM, et al. Among authors: tardif jc. Can J Cardiol. 2008 May;24 Suppl A(Suppl A):3A-8A. doi: 10.1016/s0828-282x(08)71019-5. Can J Cardiol. 2008. PMID: 18437251 Free PMC article. Review.

2

Impact of residual plaque burden after balloon angioplasty in the MultiVitamins and Probucol (MVP) trial.

Tardif JC, Côté G, Lespérance J, Gosselin G, Joyal M, de Guise P, Bilodeau L, Doucet S, Harel F, Couturier A, Gallo R, Grégoire J. Tardif JC, et al. Can J Cardiol. 2001 Jan;17(1):49-55. Can J Cardiol. 2001. PMID: 11173314 Clinical Trial.

3

Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD).

Vermes E, Ducharme A, Bourassa MG, Lessard M, White M, Tardif JC; Studies Of Left Ventricular Dysfunction. Vermes E, et al. Among authors: tardif jc. Circulation. 2003 Mar 11;107(9):1291-6. doi: 10.1161/01.cir.0000054611.89228.92. Circulation. 2003. PMID: 12628950

4

Clinical results with AGI-1067: a novel antioxidant vascular protectant.

Tardif JC. Tardif JC. Am J Cardiol. 2003 Feb 6;91(3A):41A-49A. doi: 10.1016/s0002-9149(02)03149-1. Am J Cardiol. 2003. PMID: 12645643 Review.

5

Relation between conduit vessel stiffness (assessed by tonometry) and endothelial function (assessed by flow-mediated dilatation) in patients with and without coronary heart disease.

Nigam A, Mitchell GF, Lambert J, Tardif JC. Nigam A, et al. Among authors: tardif jc. Am J Cardiol. 2003 Aug 15;92(4):395-9. doi: 10.1016/s0002-9149(03)00656-8. Am J Cardiol. 2003. PMID: 12914868

6

Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (carvedilol or metoprolol).

Blanchet M, Ducharme A, Racine N, Rouleau JL, Tardif JC, Juneau M, Marquis J, Larivée L, Nigam A, Fortier A, White M. Blanchet M, et al. Among authors: tardif jc. Am J Cardiol. 2003 Sep 1;92(5):548-53. doi: 10.1016/s0002-9149(03)00723-9. Am J Cardiol. 2003. PMID: 12943875 Clinical Trial.

7

Prevention of restenosis with antioxidants: mechanisms and implications.

Tardif JC, Grégoire J, L'Allier PL. Tardif JC, et al. Am J Cardiovasc Drugs. 2002;2(5):323-34. doi: 10.2165/00129784-200202050-00005. Am J Cardiovasc Drugs. 2002. PMID: 14727962 Review.

8

Are Canadian guidelines for cholesterol lowering in high-risk patients optimal?

Fitchett DH, Leiter LA, Tardif JC, Goodman S, Langer A. Fitchett DH, et al. Among authors: tardif jc. Can J Cardiol. 2005 Jan;21(1):85-90. Can J Cardiol. 2005. PMID: 15685308 Review.

9

Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.

Diaz A, Bourassa MG, Guertin MC, Tardif JC. Diaz A, et al. Among authors: tardif jc. Eur Heart J. 2005 May;26(10):967-74. doi: 10.1093/eurheartj/ehi190. Epub 2005 Mar 17. Eur Heart J. 2005. PMID: 15774493 Clinical Trial.

10

Sustained elevation of serum CD40 ligand levels one month after coronary angioplasty predicts angiographic restenosis.

L'Allier PL, Tardif JC, Grégoire J, Joyal M, Lespérance J, Fortier A, Guertin MC. L'Allier PL, et al. Among authors: tardif jc. Can J Cardiol. 2005 May 1;21(6):495-500. Can J Cardiol. 2005. PMID: 15917878

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results